Skip to main content
. 2011 Jan;6(1):122–132. doi: 10.2215/CJN.05750710

Table 2.

Clinical data of the recurrent disease

Patient 1 Patient 2 Patient 3 Patient 4
Age at transplant 57 62 75 40
Kidney source Living-unrelated donor Deceased donor Living-related donor Living-unrelated donor
HLA mismatch 4 of 6 HLA antigens 0 of 6 HLA antigens 2 of 6 HLA antigens 4 of 6 HLA antigens
Percent PRAa 1% for class I 0% for class I 0% for class I 0% for class I
13% for class II 0% for class II 0% for class II 0% for class II
Maintenance immunosuppressive regimen FK506/PRED/MMF FK506/PRED/Myfortic acid FK506/PRED/MMF FK506/PRED/MMF
Time from transplant to diagnosis of recurrent disease 3 4 5 3
Baseline serum creatinine (mg/dl) 1.9 1.2 1.4 0.9
Parameters at the time of first biopsy showing recurrence
    serum creatinine (mg/dl) 2.8 3.7 4.8 1.2
    24-hour urine protein 0.790 7.4 5.8 0.061
    serum albumin 3.5 2.0 3 4.4
    edema Yes Yes Yes No
    hematuria Yes Yes Yes No
    serum complement Normal C3 and C4 then low C3 and C4 3 months postbiopsy Low C3 and C4 Low C3 and C4 Normal C3 and C4
    serum paraprotein Negative (also normal serum free K:L) Negative Negative (also normal serum free K:L) Negative
    urine paraprotein Negative Negative Negative Not done
    serum cryoglobulin Negative Negative Negative Not done
    hepatitis C antibody Negative Negative Negative Not done
    ANA Negative Negative Negative Not done
Treatment of recurrent disease PRED and PO CYT for 6 months, after the third biopsy M-PRED/PO PRED for 8 months/RIT ×2/lisinopril for 6 months M-PRED/RIT ×1/PLX ×4/HD ×3 M-PRED for ACR/RIT ×2
Duration of posttransplant follow-up in months 15 11 83 63
Outcome Final serum creatinine: 2.3 mg/dl Final serum creatinine: 1.1 mg/dl Final serum creatinine: 1.3 mg/dl Final serum creatinine: 2.3 mg/dl
Final 24-hour urine protein: 0.128 g Final 24-hour urine protein: 0.390 g Final 24-hour urine protein: 0.629 g Final 24-hour urine protein: 0.059 g

PRA, panel reactive antibody; FK506, tacrolimus; HD, hemodialysis; K:L, kappa:lambda; M-PRED, methyl-prednisolone; PLX, plasmapheresis; RIT, rituximab.

a

Measured in pretransplant serum.